FINWIRES · TerminalLIVE
FINWIRES

HKG:2675

3 stories mentioning HKG:2675Updated just now

Every FINWIRES story that references HKG:2675, newest first.

What are analysts saying about HKG:2675?

Recent broker actions mentioned in FINWIRES coverage. Compiled from wire headlines; not investment advice.

What's the latest news on HKG:2675?

Asia

Edge Medical Mulls China Listing; Shares Slip 3%

Shenzhen Edge Medical (HKG:2675) is exploring a potential listing in mainland China, according to a preliminary proposal filed with the Hong Kong bourse on Friday.The medical equipment maker said it applied for pre-listing tutoring on Sept. 11.The proposed initial public offering of renminbi-denominated shares on the A-share market is subject to market conditions and approvals from shareholders and relevant regulatory authorities, Edge Medical said.The company's shares fell almost 3% in late-morning trading on Monday.

HKG:2675
Research

UOB Kay Hian Starts Shenzhen Edge Medical at Buy with HK$56 Price Target

Shenzhen Edge Medical (HKG:2675) has an average rating of buy and mean price target of HK$71.62, according to analysts polled by FactSet.

HKG:2675
Asia

Shenzhen Edge Medical Plans HK$200 Million Share Buyback

Shenzhen Edge Medical (HKG:2675) plans to repurchase up to HK$200 million of its shares in the open market under an existing shareholder mandate, according to a Tuesday Hong Kong bourse filing.The company said repurchases will be conducted from time to time, subject to market conditions.The buyback authorization may cover up to 10% of the H-shares in issue at the time of the company's Hong Kong listing.The program will remain in effect until the earlier of the company's next annual general meeting or any shareholder-approved revocation or amendment of the mandate.

HKG:2675

Track with the FINWIRES app suite

FolioX
FolioX
Track HKG:2675 in your portfolio
WheelAI
WheelAI
Analyze HKG:2675 options with the wheel strategy
StockInsider
StockInsider
See market sentiment on HKG:2675